Mechanisms of Thrombus Formation
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Hemostasis is the process that maintains the integrity of a closed, high-pressure circulatory system after vascular damage. Vessel-wall injury and the extravasation of blood from the circulation rapidly initiate events in the vessel wall and in blood that seal the breach. Circulating platelets are recruited to the site of injury, where they become a major component of the developing thrombus; blood coagulation, initiated by tissue factor, culminates in the generation of thrombin and fibrin. These events occur concomitantly (Figure 1A; also see Video, available with the full text of this article at www.nejm.org), and under normal conditions, regulatory mechanisms contain . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These endothelial mediators subserve functions as varied as local flow distribution,91 immune surveillance (in concert with perivascular cells),92 and hemostatic balance.93”
In the citing paper
“Fibrinolytic therapy helps in dissolving fibrins in occluded vessels and improving the tumor vasculature [32,33,34,35,36].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [35]
In the citing paper
“enhanced platelet reactivity and acute thrombotic occlusion of vessels are the proximate cause of myocardial infarction, stroke and the majority of deaths in patients with CVD36.”
From Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential (2018) · cites this paper as [36]
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier
MACFARLANE, R. G. (1964) · Nature · doi:10.1038/202498a0 · Cited by 1,119
Waterfall Sequence for Intrinsic Blood Clotting
Davie, E. W., & Ratnoff, O. D. (1964) · Science · doi:10.1126/science.145.3638.1310 · Cited by 1,113
The Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation
Esmon, C. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83649-3 · Cited by 1,046
Blood-borne tissue factor: Another view of thrombosis
Giesen, P. L. A., Rauch, U., Bohrmann, B., Kling, D., Roqué, M., Fallon, J. T., Badimon, J. J., Himber, J., Riederer, M. A., & Nemerson, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2311 · Cited by 991
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., & Gimbrone, M. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.618 · Cited by 935
Stability and Instability: Two Faces of Coronary Atherosclerosis: The Paul Dudley White Lecture 1995
Davies, M. J. (1996) · Circulation · doi:10.1161/01.cir.94.8.2013 · Cited by 915
Italiano, J. E., Richardson, J. L., Patel-Hett, S., Battinelli, E., Zaslavsky, A., Short, S., Ryeom, S., Folkman, J., & Klement, G. L. (2008) · Blood · doi:10.1182/blood-2007-09-113837 · Cited by 859
Trousseau's syndrome: multiple definitions and multiple mechanisms
Varki, A. (2007) · Blood · doi:10.1182/blood-2006-10-053736 · Cited by 840
Palabrica, T., Lobb, R., Furie, B. C., Aronovitz, M., Benjamin, C., Hsu, Y.-M., Sajer, S. A., & Furie, B. (1992) · Nature · doi:10.1038/359848a0 · Cited by 808
Self-citationOsterud, B., & Rapaport, S. I. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5260 · Cited by 787
Factor XI Activation in a Revised Model of Blood Coagulation
Gailani, D., & Broze, G. J. (1991) · Science · doi:10.1126/science.1652157 · Cited by 775
Falati, S., Liu, Q., Gross, P., Merrill-Skoloff, G., Chou, J., Vandendries, E., Celi, A., Croce, K., Furie, B. C., & Furie, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021868 · Cited by 752
Self-citationCD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
André, P., Prasad, K. S. S., Denis, C. V., He, M., Papalia, J. M., Hynes, R. O., Phillips, D. R., & Wagner, D. D. (2002) · Nature Medicine · doi:10.1038/nm0302-247 · Cited by 726
Defective thrombus formation in mice lacking coagulation factor XII
Renné, T., Pozgajová, M., Grüner, S., Schuh, K., Pauer, H.-U., Burfeind, P., Gailani, D., & Nieswandt, B. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050664 · Cited by 683
Antithrombotic Therapy in Neonates and Children
Monagle, P., Chalmers, E., Chan, A., deVeber, G., Kirkham, F., Massicotte, P., & Michelson, A. D. (2008) · Chest · doi:10.1378/chest.08-0762 · Cited by 676
Role of tissue factor in embryonic blood vessel development
Carmeliet, P., Mackman, N., Moons, L., Luther, T., Gressens, P., Van Vlaenderen, L., Demunck, H., Kasper, M., Breier, G., Evrard, P., et al. (1996) · Nature · doi:10.1038/383073a0 · Cited by 669
Mallat, Z., Hugel, B., Ohan, J., Lesèche, G., Freyssinet, J.-M., & Tedgui, A. (1999) · Circulation · doi:10.1161/01.cir.99.3.348 · Cited by 638
The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.
Nesheim, M. E., Taswell, J. B., & Mann, K. G. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86616-4 · Cited by 582
Michelson, A. D., Barnard, M. R., Hechtman, H. B., MacGregor, H., Connolly, R. J., Loscalzo, J., & Valeri, C. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11877 · Cited by 551 · cited 1×
“The reason for that is not clear, but different methods of platelet P-selectin measurement may be partly responsible, since P-selectin is rapidly mobilized to the platelet surface and lost in the plasma [ 19 ] .”
BackgroundMicroparticle‐associated tissue factor activity: a link between cancer and thrombosis?
TESSELAAR, M. E. T., ROMIJN, F. P. H. T. M., VAN DER LINDEN, I. K., PRINS, F. A., BERTINA, R. M., & OSANTO, S. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02369.x · Cited by 548
Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen
Nieswandt, B. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2120 · Cited by 548
Molecular and Cellular Biology of Blood Coagulation
Flier, J. S., Underhill, L. H., Furie, B., & Furie, B. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203193261205 · Cited by 530
Self-citationA Crucial Role of Glycoprotein VI for Platelet Recruitment to the Injured Arterial Wall In Vivo
Massberg, S., Gawaz, M., Grüner, S., Schulte, V., Konrad, I., Zohlnhöfer, D., Heinzmann, U., & Nieswandt, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020945 · Cited by 516
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype
Podrez, E. A., Byzova, T. V., Febbraio, M., Salomon, R. G., Ma, Y., Valiyaveettil, M., Poliakov, E., Sun, M., Finton, P. J., Curtis, B. R., et al. (2007) · Nature Medicine · doi:10.1038/nm1626 · Cited by 513
Morrissey, J., Macik, B., Neuenschwander, P., & Comp, P. (1993) · Blood · doi:10.1182/blood.v81.3.734.734 · Cited by 512
Platelets: Physiology and Biochemistry
Jurk, K., & Kehrel, B. E. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-916671 · Cited by 497
Ni, H., Denis, C. V., Subbarao, S., Degen, J. L., Sato, T. N., Hynes, R. O., & Wagner, D. D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9896 · Cited by 492
Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation?
Morel, O., Toti, F., Hugel, B., Bakouboula, B., Camoin-Jau, L., Dignat-George, F., & Freyssinet, J.-M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000246775.14471.26 · Cited by 460
Kleinschnitz, C., Stoll, G., Bendszus, M., Schuh, K., Pauer, H.-U., Burfeind, P., Renné, C., Gailani, D., Nieswandt, B., & Renné, T. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052458 · Cited by 452
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
Angelillo-Scherrer, A., de Frutos, P. G., Aparicio, C., Melis, E., Savi, P., Lupu, F., Arnout, J., Dewerchin, M., Hoylaerts, M. F., Herbert, J.-M., et al. (2001) · Nature Medicine · doi:10.1038/84667 · Cited by 441
Suzuki, K., Kusumoto, H., Deyashiki, Y., Nishioka, J., Maruyama, I., Zushi, M., Kawahara, S., Honda, G., Yamamoto, S., & Horiguchi, S. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02448.x · Cited by 364 · cited 1×
“Endothelial thrombomodulin is a key component of the protein C anticoagulant pathway, which facilitates the activation of protein C by thrombin [ 7– 9 ] .”
BackgroundRegulation of angiogenesis by tissue factor cytoplasmic domain signaling
Belting, M., Dorrell, M. I., Sandgren, S., Aguilar, E., Ahamed, J., Dorfleutner, A., Carmeliet, P., Mueller, B. M., Friedlander, M., & Ruf, W. (2004) · Nature Medicine · doi:10.1038/nm1037 · Cited by 350
Chou, J., Mackman, N., Merrill-Skoloff, G., Pedersen, B., Furie, B. C., & Furie, B. (2004) · Blood · doi:10.1182/blood-2004-03-0935 · Cited by 347
Self-citationSchmidt, B., Ho, L., & Hogg, P. J. (2006) · Biochemistry · doi:10.1021/bi0603064 · Cited by 332
Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
Salomon, O., Steinberg, D. M., Koren-Morag, N., Tanne, D., & Seligsohn, U. (2008) · Blood · doi:10.1182/blood-2007-10-120139 · Cited by 327
A critical role for extracellular protein disulfide isomerase during thrombus formation in mice
Cho, J., Furie, B. C., Coughlin, S. R., & Furie, B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34134 · Cited by 324
Self-citationReinhardt, C., von Brühl, M.-L., Manukyan, D., Grahl, L., Lorenz, M., Altmann, B., Dlugai, S., Hess, S., Konrad, I., Orschiedt, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32376 · Cited by 323
Intrinsic Pathway of Coagulation and Arterial Thrombosis
Gailani, D., & Renné, T. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.155952 · Cited by 303
Hrachovinová, I., Cambien, B., Hafezi-Moghadam, A., Kappelmayer, J., Camphausen, R. T., Widom, A., Xia, L., Kazazian, H. H., Schaub, R. G., McEver, R. P., et al. (2003) · Nature Medicine · doi:10.1038/nm899 · Cited by 296 · cited 1×
“P-selectin expressed on platelets may be a direct inducer of procoagulant activity associated with vascular and thrombotic diseases [ 6 ] .”
BackgroundHron, G., Kollars, M., Weber, H., Sagaster, V., Quehenberger, P., Eichinger, S., Kyrle, P. A., & Weltermann, A. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-03-0141 · Cited by 296
Long-term results of the lateral tunnel Fontan operation
Stamm, C., Friehs, I., Mayer, J. E., Zurakowski, D., Triedman, J. K., Moran, A. M., Walsh, E. P., Lock, J. E., Jonas, R. A., & del Nido, P. J. (2001) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.111422 · Cited by 292
Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions.
Goto, S., Ikeda, Y., Saldívar, E., & Ruggeri, Z. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci973 · Cited by 285
WANG, X., CHENG, Q., XU, L., FEUERSTEIN, G. Z., HSU, M., SMITH, P. L., SEIFFERT, D. A., SCHUMACHER, W. A., OGLETREE, M. L., & GAILANI, D. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01236.x · Cited by 278
Tissue factor activity in whole blood
Butenas, S., Bouchard, B. A., Brummel-Ziedins, K. E., Parhami-Seren, B., & Mann, K. G. (2005) · Blood · doi:10.1182/blood-2004-09-3567 · Cited by 278
Holtkötter, O., Nieswandt, B., Smyth, N., Müller, W., Hafner, M., Schulte, V., Krieg, T., & Eckes, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112307200 · Cited by 274
Hugel, B., Socié, G., Vu, T., Toti, F., Gluckman, E., Freyssinet, J.-M., & Scrobohaci, M.-L. (1999) · Blood · doi:10.1182/blood.v93.10.3451.410k27_3451_3456 · Cited by 259
Identification of Active Tissue Factor in Human Coronary Atheroma
Marmur, J. D., Thiruvikraman, S. V., Fyfe, B. S., Guha, A., Sharma, S. K., Ambrose, J. A., Fallon, J. T., Nemerson, Y., & Taubman, M. B. (1996) · Circulation · doi:10.1161/01.cir.94.6.1226 · Cited by 254
The MET oncogene drives a genetic programme linking cancer to haemostasis
Boccaccio, C., Sabatino, G., Medico, E., Girolami, F., Follenzi, A., Reato, G., Sottile, A., Naldini, L., & Comoglio, P. M. (2005) · Nature · doi:10.1038/nature03357 · Cited by 250
Ngo, J. C. K., Huang, M., Roth, D. A., Furie, B. C., & Furie, B. (2008) · Structure · doi:10.1016/j.str.2008.03.001 · Cited by 244
Self-citationCerebrovascular events in adult patients with cyanotic congenital heart disease
Ammash, N., & Warnes, C. A. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00196-9 · Cited by 239 · cited 5×
“Cyanotic congenital heart disease (CCHD) is associated with an increased risk of stroke and thromboembolism [ 11, 12 ] .”
BackgroundInfluentialHuman platelets synthesize and express functional tissue factor
Panes, O., Matus, V., Sáez, C. G., Quiroga, T., Pereira, J., & Mezzano, D. (2007) · Blood · doi:10.1182/blood-2006-06-030619 · Cited by 237
Glycoprotein VI–dependent and –independent pathways of thrombus formation in vivo
Dubois, C., Panicot-Dubois, L., Merrill-Skoloff, G., Furie, B., & Furie, B. C. (2006) · Blood · doi:10.1182/blood-2005-09-3687 · Cited by 236
Self-citationBergmeier, W., Piffath, C. L., Goerge, T., Cifuni, S. M., Ruggeri, Z. M., Ware, J., & Wagner, D. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608207103 · Cited by 233
Regulation of Extrinsic Pathway Factor Xa Formation by Tissue Factor Pathway Inhibitor
Baugh, R. J., Broze, G. J., & Krishnaswamy, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4378 · Cited by 226
A factor X-activating cysteine protease from malignant tissue.
Gordon, S. G., & Cross, B. A. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110203 · Cited by 219
Beyond Unfractionated Heparin and Warfarin: Current and Future Advances
Hirsh, J., O’Donnell, M., & Eikelboom, J. W. (2007) · Circulation · doi:10.1161/circulationaha.106.685974 · Cited by 211
Expression of tissue factor procoagulant activity: regulation by cytosolic calcium.
Bach, R., & Rifkin, D. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6995 · Cited by 209
Bülzebruck, H., Bopp, R. K., Drings, P., Bauer, E., Kysa, S., Probsf, G., KAICK, G. V., Müller, K. M., & Vogt-Moykopf, I. (1992) · Cancer · doi:10.1002/1097-0142(19920901)70:5<1194::aid-cncr2820700528>3.0.co;2-e · Cited by 205
Evidence for Activation of Tissue Factor by an Allosteric Disulfide Bond
Chen, V. M., Ahamed, J., Versteeg, H. H., Berndt, M. C., Ruf, W., & Hogg, P. J. (2006) · Biochemistry · doi:10.1021/bi061271a · Cited by 188
Dubois, C., Panicot-Dubois, L., Gainor, J. F., Furie, B. C., & Furie, B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30537 · Cited by 186
Self-citationLong range propagation of conformational changes in integrin alpha IIb beta 3.
Du, X., Gu, M., Weisel, J. W., Nagaswami, C., Bennett, J. S., Bowditch, R., & Ginsberg, M. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49429-5 · Cited by 183
Regulation of blood coagulation by the protein C system
Walker, F. J., & Fay, P. J. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.8.1317308 · Cited by 183 · cited 1×
“The endothelium may be damaged by the increased shear stress on the vessel wall caused by increased blood viscosity and/or by chronic hypoxemia in CCHD [ 7 ] .”
BackgroundVandendries, E. R., Hamilton, J. R., Coughlin, S. R., Furie, B., & Furie, B. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610188104 · Cited by 180
Self-citationRisk of stroke in adults with cyanotic congenital heart disease.
Perloff, J. K., Marelli, A. J., & Miner, P. D. (1993) · Circulation · doi:10.1161/01.cir.87.6.1954 · Cited by 175 · cited 1×
“Erythrocytosis and hyperviscosity itself do not increase the chance of cerebral thromboembolic events in adults [ 35 ] , and therefore phlebotomy is not recommended.”
BackgroundAssociation of tissue factor activity with the surface of cultured cells.
Maynard, J. R., Heckman, C. A., Pitlick, F. A., & Nemerson, Y. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107992 · Cited by 173
Gross, P. L., Furie, B. C., Merrill‐Skoloff, G., Chou, J., & Furie, B. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405193 · Cited by 166
Self-citationPulmonary thrombosis in adults with Eisenmenger syndrome
Silversides, C. K., Granton, J. T., Konen, E., Hart, M. A., Webb, G. D., & Therrien, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.022 · Cited by 161
Role of CD39 (NTPDase-1) in Thromboregulation, Cerebroprotection, and Cardioprotection
Marcus, A. J., Broekman, M. J., Drosopoulos, J. H. F., Olson, K. E., Islam, N., Pinsky, D. J., & Levi, R. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-869528 · Cited by 156
Cross-talk of Integrin α3β1 and Tissue Factor in Cell Migration
Dorfleutner, A., Hintermann, E., Tarui, T., Takada, Y., & Ruf, W. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0640 · Cited by 155
Prévost, N., Woulfe, D. S., Jiang, H., Stalker, T. J., Marchese, P., Ruggeri, Z. M., & Brass, L. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404065102 · Cited by 154
Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRγ deficiency
Mangin, P., Yap, C. L., Nonne, C., Sturgeon, S. A., Goncalves, I., Yuan, Y., Schoenwaelder, S. M., Wright, C. E., Lanza, F., & Jackson, S. P. (2006) · Blood · doi:10.1182/blood-2005-10-4244 · Cited by 152
Li, J. S., Yow, E. S., Berezny, K., Bokesch, P. M., Takahashi, M., Graham, T. P., Sanders, S. P., Sidi, D., Bonnet, D., Ewert, P., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.715821 · Cited by 151 · cited 1×
“Among antiplatelet medications, clopidogrel is an option [ 46 ] .”
BackgroundMinding the gaps to promote thrombus growth and stability
Brass, L. F., Zhu, L., & Stalker, T. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26869 · Cited by 148
Protein Disulfide Isomerase and Sulfhydryl-Dependent Pathways in Platelet Activation
Essex, D. W., Li, M., Miller, A., & Feinman, R. D. (2001) · Biochemistry · doi:10.1021/bi002454e · Cited by 136
Burgess, J. K., Hotchkiss, K. A., Suter, C. M., Dudman, N. P. B., Szöllõsi, J., Chesterman, C. N., Chong, B. H., & Hogg, P. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9758 · Cited by 128
Thromboembolic complications after Fontan procedures: comparison of different therapeutic approaches
Seipelt, R. G., Franke, A., Vazquez-Jimenez, J. F., Hanrath, P., von Bernuth, G., Messmer, B. J., & Mühler, E. G. (2002) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)03677-9 · Cited by 126 · cited 1×
“The probability of freedom from thromboembolism decreases with the interval after the Fontan procedure [ 26, 27 ] .”
MethodMinamino, T., Kitakaze, M., Sanada, S., Asanuama, H., Kurotobi, T., Koretsune, Y., Fukunami, M., Kuzuya, T., Hoki, N., & Hori, M. (1998) · Circulation · doi:10.1161/01.cir.98.17.1721 · Cited by 125
Versteeg, H. H., & Ruf, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702410200 · Cited by 117
LICHTMAN, M., SPIVAK, J., Boxer, L. A., Shattil, S. J., & Henderson, E. (2000) · Elsevier eBooks · doi:10.1016/b978-012448510-5/50136-9 · Cited by 116
Old concepts and new developments in the study of platelet aggregation
Ruggeri, Z. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9604 · Cited by 114
Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis
Downing, L. J., Wakefield, T. W., Strieter, R. M., Prince, M. R., Londy, F. J., Fowlkes, J. B., Hulin, M. S., Kadell, A. M., Wilke, C. A., Brown, S. L., et al. (1997) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(97)70211-8 · Cited by 111
Kario, K., Matsuo, T., Kobayashi, H., Asada, R., & Matsuo, M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.6.734 · Cited by 111 · cited 1×
“[ 21 ] demonstrated that endothelial cell damage is a potential risk factor for cerebral infarction.”
BackgroundLupu, C., Westmuckett, A. D., Peer, G. T., Ivanciu, L., Zhu, H., Taylor, F. B., & Lupu, F. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61204-7 · Cited by 110
Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia
Horigome, H., Hiramatsu, Y., Shigeta, O., Nagasawa, T., & Matsui, A. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01718-7 · Cited by 109 · cited 2×
“An elevated plasma P-selectin level has been reported in patients with congestive heart failure, primary pulmonary hypertension, and CCHD [ 18 ] .”
BackgroundA New Role for P-Selectin in Shear-Induced Platelet Aggregation
Merten, M., Chow, T., Hellums, J. D., & Thiagarajan, P. (2000) · Circulation · doi:10.1161/01.cir.102.17.2045 · Cited by 109 · cited 1×
“The platelet activation under these conditions could be due to the increased shear stress and/or endothelial dysfunction [ 23 ] .”
BackgroundPlatelet aggregation induces platelet aggregate stability via SLAM family receptor signaling
Nanda, N., Andre, P., Bao, M., Clauser, K., Deguzman, F., Howie, D., Conley, P. B., Terhorst, C., & Phillips, D. R. (2005) · Blood · doi:10.1182/blood-2005-01-0333 · Cited by 107
Semeraro, N., Biondi, A., Lorenzet, R., Locati, D., Mantovani, A., & Donati, M. B. (1983) · PubMed Central · Cited by 107
The Tissue Factor Requirement in Blood Coagulation
Orfeo, T., Butenas, S., Brummel‐Ziedins, K. E., & Mann, K. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505506200 · Cited by 104
Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa
Hathcock, J. J., & Nemerson, Y. (2004) · Blood · doi:10.1182/blood-2003-12-4352 · Cited by 100
Allosteric disulfide bonds in thrombosis and thrombolysis
Chen, V. M. Y., & Hogg, P. J. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02236.x · Cited by 98
Kaulitz, R., Ziemer, G., Rauch, R., Girisch, M., Bertram, H., Wessel, A., & Hofbeck, M. (2005) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.08.045 · Cited by 97 · cited 1×
“[ 42 ] reported that thrombotic events were observed in 7 % of patients long after TCPC, and the incidence was similar among patients without medication, with aspirin, and with warfarin.”
BackgroundFerreiro, C., Chagas, A. C. P., de Carvalho, M. H. C., Dantas, A. P., Jatene, M. B., de Souza, L. C. B., & da Luz, P. L. (2001) · Circulation · doi:10.1161/01.cir.103.18.2272 · Cited by 94
Results of 546 Blalock-Taussig shunts performed in 478 patients
Jubair, K. A. A., Fagih, M. R. A., Al-Jarallah, A. S., Yousef, S. A., Khan, M., Ashmeg, A. K., Faraidi, Y. A., & Sawyer, W. A. (1998) · Cardiology in the Young · doi:10.1017/s1047951100007150 · Cited by 93 · cited 1×
“Bene fi cial effects of antiplatelets are shown in some studies [ 36, 37 ] , but not in others [ 38, 39 ] .”
BackgroundThe role of platelets in decrypting monocyte tissue factor
Østerud, B. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90139-8 · Cited by 78
The Fontan procedure: analysis of cohorts and late complications
Freedom, R. M., Hamilton, R. M., Yoo, S., Mikailian, H., Benson, L. N., McCrindle, B. W., Justino, H., & Williams, W. G. (2000) · Cardiology in the Young · doi:10.1017/s1047951100009616 · Cited by 74 · cited 2×
“A Fontan circulation is associated with an increased risk of thromboembolism [ 24– 26 ] .”
BackgroundMethodLevin, E., Wu, J. K., Alexander, J., Reichart, C., Sett, S. S., Seear, M. D., & Devine, D. V. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613757 · Cited by 73 · cited 2×
“Some studies failed to demonstrate elevated platelet P-selectin in patients with CCHD [ 14, 18 ] .”
BackgroundRoqué, M., Reis, E. D., Fuster, V., Padurean, A. M., Fallon, J. T., Taubman, M. B., Chesebro, J. H., & Badimón, J. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01018-4 · Cited by 73
P-Selectin Antagonism Causes Dose-dependent Venous Thrombosis Inhibition
Schaub, R., Wrobleski, S. K., Londy, F. J., Fex, B. A., Chapman, A., Greenfield, L. J., Wakefield, T. W., & Myers, D. D. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615622 · Cited by 69
Plasma levels of thrombomodulin in pulmonary hypertension
Cacoub, P., Karmochkine, M., Dorent, R., Nataf, P., Piette, J. C., Godeau, P., Gandjbakhch, I., & Boffa, M. C. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)80070-2 · Cited by 69 · cited 2×
“It has been speculated that in patients with primary pulmonary hypertension, damage to the endothelium leads to a decreased thrombomodulin level [ 10 ] .”
BackgroundCOX Inhibitors and Thromboregulation
Marcus, A. J., Broekman, M. J., & Pinsky, D. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcibr021805 · Cited by 69
The Factor V Activation Paradox
Orfeo, T., Brufatto, N., Nesheim, M. E., Xu, H., Butenas, S., & Mann, K. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400727200 · Cited by 69
Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity
Dietzen, D. J., Page, K. L., & Tetzloff, T. A. (2004) · Blood · doi:10.1182/blood-2003-07-2399 · Cited by 65
Cross‐strand disulphides in cell entry proteins: poised to act
Wouters, M. A., Lau, K. K., & Hogg, P. J. (2004) · BioEssays · doi:10.1002/bies.10413 · Cited by 64
Impaired vascular function in patients with Fontan circulation
Jin, S. M., Noh, C. I., Bae, E. J., Choi, J. Y., & Yun, Y. S. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.09.020 · Cited by 63 · cited 1×
“Previous studies using near-infrared spectroscopy and fl ow-mediated vasodilation have suggested that endothelial function in Fontan patients is impaired [ 34 ] .”
ResultThromboembolism and the Role of Anticoagulation in the Fontan Patient
Jacobs, M. L., & Pourmoghadam, K. K. (2007) · Pediatric Cardiology · doi:10.1007/s00246-007-9006-1 · Cited by 63 · cited 1×
“Irrespective of the antithrombotic medication policy, Jacobs and Pourmoghadam [ 44 ] emphasized the importance of careful evaluation of thrombosis in the follow-up of post-Fontan patients, including transesophageal echocardiography.”
BackgroundLiebman, H. A., & Feinstein, D. I. (2003) · Thrombosis Research · doi:10.1016/j.thromres.2003.09.018 · Cited by 60
Feedback activation of factor XI by thrombin does not occur in plasma
Pedicord, D. L., Seiffert, D., & Blat, Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705566104 · Cited by 57
Bedard, P. W., Clerin, V. M., Sushkova, N., Tchernychev, B., Antrilli, T. M., Resmini, C., Keith, J. C., Hennan, J. K., Kaila, N., DeBernardo, S., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.128124 · Cited by 54
Long-term anticoagulation therapy and thromboembolic complications after the Fontan procedure
Cheung, Y., Chay, G. W., Chiu, C. S. W., & Cheng, L. C. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.05.051 · Cited by 52 · cited 1×
“[ 43 ] also reported similar data.”
Horigome, H., Murakami, T., Isobe, T., Nagasawa, T., & Matsui, A. (2003) · Thrombosis Research · doi:10.1016/j.thromres.2003.12.011 · Cited by 48 · cited 2×
“Previous studies showed decreased plasma thrombomodulin levels of protein C activity in patients with CCHD [ 16, 17 ] .”
BackgroundMethodTissue factor-positive microparticles in blood associated with coagulopathy in cancer
Antoniak, S., & Rauch, U. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-12-0687 · Cited by 41
Reduced frequency of occlusion of aorto-pulmonary shunts in infants receiving Aspirin
Motz, R., Wessel, A., Ruschewski, W., & Bürsch, J. (1999) · Cardiology in the Young · doi:10.1017/s1047951100005370 · Cited by 36 · cited 1×
“Bene fi cial effects of antiplatelets are shown in some studies [ 36, 37 ] , but not in others [ 38, 39 ] .”
BackgroundIncreased P-Selectin Expression on Platelets and Decreased Plasma Thrombomodulin in Fontan Patients
Kajimoto, H., Nakazawa, M., Murasaki, K., Hagiwara, N., & Nakanishi, T. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1087 · Cited by 34 · cited 3×
“We also showed previously that plasma thrombomodulin levels and protein C activity were decreased in Fontan patients [ 33 ] , suggesting the presence of impaired endothelial function.”
BackgroundMethodInfluentialBinotto, M. A., Maeda, N. Y., & Lopes, A. A. (2005) · Cardiology in the Young · doi:10.1017/s1047951105000065 · Cited by 33 · cited 1×
“In the presence of right-to-left shunt before Fontan completion, it may be prudent to use antiplatelets and/or anticoagulants in patients after the Glenn procedure [ 45 ] .”
MethodAdatia, I., Barrow, S. E., Stratton, P., Ritter, J. M., & Haworth, S. G. (1993) · Heart · doi:10.1136/hrt.69.2.179 · Cited by 29 · cited 1×
“The precise mechanisms behind the increased incidence of thromboembolism in patients with CCHD have not yet been determined, but endothelial dysfunction, coagulation abnormalities, platelet activation, and an abnormal bloodstream may be underlying factors causing thromboembolism [ 14, 15 ] .”
BackgroundStone, M. D., Harvey, S. B., Martinez, M. B., Bach, R. R., & Nelsestuen, G. L. (2005) · Biochemistry · doi:10.1021/bi050007z · Cited by 8
Use of acetylsalicylic acid to improve patency of subclavian to pulmonary artery Gore-Tex shunts.
Centazzo, S., Montigny, M., Davignon, A., Chartrand, C., Fournier, A., & Marchand, T. (1993) · PubMed · Cited by 6
Research works printed but not linked: 4
- Semeraro N, 1983, Immunology, 50, 529
- Reinhardt C, 2008, J Clin Invest, 118, 1110
- Cho J, 2008, J Clin Invest, 118, 1123
- 1986, Lancet, 1, 397
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Wound Healing: A Cellular Perspective
Rodrigues, M., Kosaric, N., Bonham, C. A., & Gurtner, G. C. (2019) · Physiological Reviews · doi:10.1152/physrev.00067.2017 · Cited by 3,013
“Next, primary hemostasis and secondary hemostasis occur via two concurrent and mechanistically intertwined pathways (129).”
BackgroundThrombosis as an intravascular effector of innate immunity
Engelmann, B., & Massberg, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3345 · Cited by 1,989
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
“However, at sites of vessel injury, platelets are rapidly activated by stimulus-dependent mobilization of [Ca2+]i, a precursor to thrombus formation and hemostasis (Rink and Sage, 1990; Furie and Furie, 2008).”
InfluentialClassification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
“…trigger thrombus formation in vivo (Biró et al., 2003), are abundantly present in human atherosclerotic plaques (Mallat et al., 1999), and may be deposited at a site of vascular injury by binding to activated platelets (Furie and Furie, 2004; Del Conde et al., 2005; Furie and Furie, 2008).”
Background
Metadata
- Authors
- Furie, B., & Furie, B. C.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- ORCID
- Furie, Bruce
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-08-28
- Volume
- 359
- Issue
- 9
- Pages
- 938-949
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1983760732
- Cited by
- 1,926
- References
- 122
- Citations by year
- 2026: 75 · 2025: 119 · 2024: 114 · 2023: 121 · 2022: 110 · 2021: 117 · 2020: 103 · 2019: 96 · 2018: 93 · 2017: 109 · 2016: 108 · 2015: 122 · 2014: 101 · 2013: 119 · 2012: 106
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL087203)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- thrombus formation, hemostasis, platelet recruitment, coagulation, tissue factor, thrombin, fibrin, vascular injury, coagulation regulation
- MeSH terms
- Animals, Blood Coagulation, Blood Coagulation Disorders, Fibrinolytic Agents, Humans, Neoplasms, Thrombosis, Platelet Activation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.